The generation of synthetic placebo data for ALS clinical trials
Reading Time: 5 minutes In this guest blog written by Harry Bowles and Sarah Opie-Martin from King’s College London they discuss their MND research poster which was presented at the European Network to Cure ALS (ENCALS) meeting in June 2022. Randomised, double blind trials are the gold standard During a clinical trial, a group of volunteers with ALS are…